Protective role of DLα-lipoic acid against adriamycin-induced cardiac lipid peroxidation

Human and Experimental Toxicology

Volumn 22, Issue 5, 2003, Pages 249-254

  Balachandar, A V ^a   Malarkodi, K P ^a   Varalakshmi, P ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Adriamycin; Cardiotoxicity; Lipid peroxidation; Lipoic acid

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CREATINE KINASE; CRYOPROTECTIVE AGENT; DOXORUBICIN; FREE RADICAL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEART ENZYME; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CARDIOTOXICITY; CELLULAR IMMUNITY; CHRONIC TOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CRYOPROTECTION; DRUG POTENCY; ENZYME ACTIVITY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TOXICITY TESTING; ANIMAL; ARTICLE; CATTLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEART INJURY; WISTAR RAT;

ANIMALIA; RATTUS NORVEGICUS;

ANIMALS; ANTIOXIDANTS; CATTLE; DOXORUBICIN; FREE RADICALS; HEART INJURIES; LIPID PEROXIDATION; MALE; RATS; RATS, WISTAR; THIOCTIC ACID;

EID: 0038476528     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327103ht358oa     Document Type: Review

References (51)

1. Booser DJ, Hortobagayi GN. Antracycline antibiotic in cancer therapy focus on drug resistance. Drugs 1994; 47: 223-58.
2. Yin X, Wu H, Chen Y, Kang YJ. Induction of antioxidants by adriamycin in mouse heart. Biochem Pharmacol 1998; 56: 87-93.
3. Hershko C, Link G, Tzahour M, Pinson A. The role of iron and iron chelators in anthracycline cardiotoxicity. Leuk Lymphoma 1993; 11: 207-14.
4. Thomas CE, Aust SD. The release of iron from ferritin by cardiotoxic anthracycline antibiotic. Arch Biochem Biophys 1986; 248: 684-89.
5. Sinha BK, Politi PM. Anthracyclines. Cancer Chemother Biol Response Modif 1990; 11: 45-57.
6. Singal PK, Iliskovic N. Current concepts; doxorubicin induced cardiomyopathy. N Engl J Med 1998; 339: 900-905.
7. Myers CE, McGuire WP, Liss RH, Ifrim J, Grotzinger K, Young RC. Adriamycin. The role of lipid peroxidation in cardiac toxicity and tumour response. Science 1977; 197: 165-67.
8. Mimnaugh EG, Trush MA, Bhatanagar M, Gram TE. Enhancement of reactive oxygen dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin. Biochem Pharmacol 1985; 34: 847-56.
9. Olsan RD, Mushlin PS. Doxorubicin cardiotoxicity: analysis of prevailing hypothesis. FASEB J 1990; 34: 3076-86.
10. Sohal RS, Ku HH, Agarwal S, Forster MJ, Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defences during ageing and its response to food restriction in the mouse. Mech Ageing Dev 1994; 74: 121-33.
11. Kagan VE, Shvedova A, Serbinova E, Khan S, Swason C. Dihydro lipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Biochem Pharm 1992; 44: 1637-49.
12. Sumathi R, Jayanthi S, Kaplanadevi V, Varalakshmi P. Effect of dl alpha lipoic acid on tissue lipid peroxidation and antioxidant systems in normal and glycollate treated rats. Pharm Res 1993; 27: 309-18.
13. Sumathi R, Kalpana devi V, Varalakshmi P. DLa-alpha lipoic acid protection against cadmimum induced tissue lipid peroxidation. Med Sci Res 1994; 22: 23-25.
14. Sandhya P, Varalakshmi P. Effect of DL-Alpha Lipoic acid administration on Gentamicin induced lipid peroxidation in rats. J Appl Toxicol 1998; 17: 405-408.
15. Prehn JHM, Karkoutiny C, Nuglisch J, Peruche B, Krieglstein J. Dihydrolipoate reduces neurol injury after cerebral ischemia. J Cereb Blood Flow Metab 1992; 12: 78-87.
16. Fuchs J, Schofer H, Milbradt R, Friesleben HJ, Buhl R, Siems W et al. Studies of lipoate effects on blood redox state in HIV infected patients. Arznemforsch Drug Res 1993; 43: 1359-62.
17. SuH JH, Shigeno ET, Marrow JD, Cox B, Rocha AE, Frej B et al. Oxidative stress in the ageing rat heart is reversed by dietary supplementation with (R) alpha lipoic acid. FASEB J 2001; 75: 700-706.
18. Kagan V, Khan S, Swanson C, Shvedova A, Serbinova E, Packer L. Antioxidant action of thioctic acid and dihydrolipoic acid. Free Radic Biol Med 1990; 9 (Suppl): 15.
19. Hagen TM, Ingersoll RT, Lykkesfeld J, Liu J, Wehr CM, Vinarsky V et al α-lipoic acid supplemented old rats have improved mitochondrial function, decreased oxidative damage and increased metabolic rate. FASEB J 1999: 13: 411-18.
20. Ford CA, Parai S, Longerich L, Gadag V. Dietary α-Lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertension 2000; 18: 567-73.
21. Mettler P, Young D, Ward J. Adriamycin induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. Cancer Res 1977; 37: 2705-13.
22. Devasagayam TPA. Lipid peroxidation rat uterus. Biochim Biophys Acta 1986; 876: 507-14.
23. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389-94.
24. Marklund S, Marklund G. Involvement of superoxide anion radicals in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-74.
25. Rotruk JT, Popew AC, Ganther HE, Swason AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179; 588-90.
26. Moron MS, Defierre JW, Mannervik KB. Levels of glutathione, glutathione peroxidase and glutathione S-transferase in rat lung and liver. Biochem Biophys Acta 1979; 582: 67-78.
27. Staal GEJ, Visser J, Veeger C. Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta 1969; 185: 39-48.
28. Beutler E. Active transport of glutathione disulphide from erythrocytes. In Larson A, Orrenius S, Holmgrem A, Mannerwik B eds. Functions of glutathione: biochemical, physiological, toxicological and clinical aspects. New York: Raven Press: 65.
29. Omaye ST, Turnbull JD, Sauberlich HE. Selected methods for the determinations of ascorbic acid in animal cell, tissues and fluids. Methods Enzymol 1979; 67: 1-11.
30. Quaife MC, Bju MY. Chemical estimations of Vitamin E in tissues and alpha tocopherol content of normal tissues. J Biol Chem. 1948; 180: 263-272
31. Baker AF, Frank G. Estimation of vitamin E in tissues In Bollinger HR ed. Dunnschicht chromatographic in loboratorium 'Handbrich'. Berlin: Springer Verlag, 1951: 41-52
32. King J. Dehydrogenase or oxidoreductases, lactate dehydrogenases. In Van D ed. Practical clinical enzymology. London: Nostrand Company Ltd, 1965: 83-93.
33. Okinaka H, Kamagai E, Ehashi H, Sugita H, Mamoi T, Toyokura S et al. Serum CPK activity in progressive muscular dystrophy and neuromuscular disease. Ann Neurol 1961; 41: 520-25.
34. Lowry OH, Roseberg NJ, Farr AL, Randall RJ. Protein measurements with folin phenol reagent. J Biol Chem 1951; 193: 265-75.
35. Olson HM, Capen CC. Chronic cardiotoxicity of doxorubicin in the rat. Morphologic and biochemical investigation. Toxicol Appl Pharmacol 1978; 44: 605-616.
36. Monnet E, Orton C. A canine model of heart failure by intracoronary adriamycin injection; hemodynamic and energetic results. J Card Fail 1999; 5: 255-64.
37. Kosowar EM. Role of glutathione in muscle contractile function. Experintia 1970; 26: 760.
38. Glavin MJ, Lefer AM. A salutatory effect of cysteine on cardiogenic shock in cats. Am J Physiol 1978; 235: 657
39. Serbinova E, Khwaja S, Rezneick AZ, Packer L. Thioctic acid protects against ischemia-reperfusion injury in the isolated perfused langerdorff heart. Free Radic Res Commun 1992; 17: 49-58.
40. Freisleben HJ. Lipoic acid reduces ischemia repurfusion injury in animal models. Toxicology 2000; 148: 159-71.
41. Olson RD, McDonald JS, Van Boxtel CJ, Boerth RC, Harbison RD et al. Regulatory role of glutathione and soluble sulphydryl groups in the toxicity of adriamycin. J Pharmacol Exp Ther 1980; 215: 450-54.
42. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4 hydroxynoneal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
43. Javor T, Tarnok F, Past Tand Nagy S. Lipoic acid cytoprotective effect of free radical scavengers against mucosal damage produced by different antireheumatic drugs. Int J Tissue React. 1986; 8: 35-40.
44. Al-Majed AA., Gado AM., Aal-Shabanah OA, Mansour MA. Alpha lipoic acid ameliorates myocardial toxicity induced Doxorubicin. Pharm Res 2002; 46: 499-503.
45. Zhou GY, Zhao BL, Hou JW, Ma GE, Xin WJ. Protective effects of odium thanshione II a sulphonate against adriamycin induced lipid peroxidation in mice hearts in vivo and in vitro. Pharmacol Res 1999; 40: 487-91.
46. Munday R, Winterburn CC. Reduced GSH in combination with SOD as an important biological antioxidant defence mechanism. Biochem Pharmacol 1989; 38: 4349-52.
47. Sumathi R, Baskaran G, Varalakshmi P. Relationship between GSH and DLα-Lipoic acid against cadmium induced hepatotoxicity. Jpn J Med Sci Biol 1996; 49: 39-48.
48. Marchioli R. Antioxidants vitamins and prevention of cardiovascular disease; laboratory, epidemiological and clinical trial data. Pharmacol Res 1999; 40: 227-38.
49. Packer L, Witt EH, Tritschiler HJ. A review: Alpha lipoic acid. Acts as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-50.
50. Muller L, Menzel H. Studies on the efficacy of lipoate and dihydrolipoate in the alterations of cadmium toxicity in isolated hepatocytes. Biochim Biophys Acta 1990; 1052: 385-91.
51. Pruijn FB, Haenen GRMM, Bast A. Interplay between Vit E, glutathione and dihydrolipoic acid in protection against lipid peroxidation. Fat Sci Technol 1991; 93: 216-21.